1-5 of 5
Tiba Al Sagheer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real World Experience with Sequential Brentuximab Vedotin Plus AVD Chemotherapy As Frontline Therapy for Older Patients with Classical Hodgkin Lymphoma: A Multicenter Retrospective Study

Ariel Perez Perez, Nayef Abdel-Razeq, Tiba Al Sagheer, George Nahas, Jose Sandoval-Sus, Manny Alfonso, Carlos Silva, Syeda Saba Kareem, Katherine Tobon, Allison C. Rosenthal, Stephen M. Ansell, Yuliya PL Linhares, Muhamad Alhaj Moustafa, Hayder Saeed
Journal: Blood
Blood (2024) 144 (Supplement 1): 1672.
https://doi.org/10.1182/blood-2024-208781
Published: 2024
Journal Articles

CD20xCD3 Bispecific Antibodies As Standard of Care (SOC) for Relapse/Refractory (R/R) Large B-Cell Lymphoma (LBCL) - a Multicenter Retrospective Study

Ning Dong, Sushmita Khadka, Jose Sandoval-Sus, Carlos Silva Rondon, Ariel Perez, Tiba Al Sagheer, Madiha Iqbal, Juan Pablo Alderuccio, Cristian Rodriguez Arocho, Syeda Saba Kareem, Michael D. Jain, Julio C. Chavez
Journal: Blood
Blood (2024) 144 (Supplement 1): 3091.
https://doi.org/10.1182/blood-2024-203538
Published: 2024
Journal Articles

Rituximab Ibrutinib Lenalidomide (R2I) Combination for Primary or Secondary Large B-Cell CNS Lymphoma: Last Resort or Bridge to Cellular Therapy?

Ariel Perez Perez, Tiba Al Sagheer, George Nahas, Muni Rubens, Kristie Lopes, Yazmin Odia, Manmeet Ahluwalia, Zhijian Chen, Yuliya Linhares
Journal: Blood
Blood (2023) 142 (Supplement 1): 6275.
https://doi.org/10.1182/blood-2023-186488
Published: 2023
Journal Articles

Polatuzumab- Rituximab with or without Bendamustine As Second-Line Therapy for Relapsed Refractory Large B-Cell Lymphomas: Single Center Experience

Ariel Perez Perez, Shreya Saxena, Tiba Al Sagheer, Muni Rubens, Talia Zahra, George Nahas, Alex V. Mejia Garcia, Lyle Feinstein, Lisa Reale, Marco Andres Ruiz, Peter L. Citron, Atulya Khosla, Manmeet Ahluwalia, Guenther Koehne, Yuliya P.L. Linhares
Journal: Blood
Blood (2022) 140 (Supplement 1): 6672–6673.
https://doi.org/10.1182/blood-2022-163461
Published: 2022
Journal Articles

Trial in Progress: Zanubrutinib with Pemetrexed for the Treatment of Relapsed/Refractory Primary and Secondary CNS Lymphomas: A Phase II Trial with a Safety Lead-in

Yuliya Linhares, Ariel Perez Perez, Tiba Al Sagheer, George Nahas, Alex Mejia-Garcia, Muni Rubens, Talia Zahra, Lyle Feinstein, Lisa Reale, Marco Andres Ruiz, Peter L. Citron, Yazmin Odia, Guenther Koehne
Journal: Blood
Blood (2022) 140 (Supplement 1): 12061–12063.
https://doi.org/10.1182/blood-2022-167064
Published: 2022